References
British Society for Antimicrobial Chemotherapy (BSAC UK) (2014) Resistance Surveillance Project [Online]. Available at www.bsacsurv.org/reports/bacteraemia#results (Accessed 29 November 2017).
Center for Disease Control (CDC) (2017) About Antimicrobial Resistance [Online]. Available at www.cdc.gov/ drugresistance/ about.html [Tip: hold Ctrl and click a link to open it in a new tab. (Hide tip)] (Accessed 20 November 2017).
Cox, G. and Wright, G. (2013) ‘Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions’, International Journal of Medical Microbiology, vol. 303, no. 6–7, pp. 287–92 [Online]. Available at www.sciencedirect.com/ science/ article/ pii/ S1438422113000246 (Accessed 27 November 2017).
Duplessis, C. and Crum-Cianflone, N. F. (2011) ‘Ceftaroline: a new cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA)’, Clinical Medicine Reviews in Therapeutics, vol. 3, pp. 24–66 [Online]. Available at www.ncbi.nlm.nih.gov/ pmc/ articles/ PMC3140339/ (Accessed 27 November 2017).
Hernández-Allés, S., Conejo, M., Pascual, A., Tomás, J., Benedí, V. and Martínez-Martínez, L. (2000) ‘Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae’, Journal of Antimicrobial Chemotherapy, vol. 46, no. 2, pp. 273–7 [Online]. Available at https://academic.oup.com/ jac/ article/ 46/ 2/ 273/ 881421 (Accessed 30 November 2017).
Kisgen, J and Whitney, D. (2008) ‘Ceftobiprole, a broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA)’, Pharmacy and Therapeutics, vol. 33, no. 11, pp. 631–41 [Online]. Available at www.ncbi.nlm.nih.gov/ pmc/ articles/ PMC2730812/ (Accessed 27 November 2017).
Kosmidis, C. Schindler, B., Jacinto, P., Patel, D., Bains, K., Seo, S. and Kaatz, G. (2012) ‘Expression of multidrug resistance efflux pump genes in clinical and environmental isolates of Staphylococcus aureus’, International Journal of Antimicrobial Agents, vol. 40, no. 3, pp. 204–9 [Online]. Available at www.ijaaonline.com/ article/ S0924-8579(12)00184-7/ fulltext (Accessed 24 November 2017).
Lim, D. and Strynadka, N. C. J. (2002) ‘Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus’, Nature Structural Biology, vol. 9, no. 11, pp. 870–6 [Online]. Available at www.nature.com/ articles/ nsb858 (Accessed 27 November 2017).
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S. and Vester, B. (2006) ‘The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics’, Antimicrobial Agents and Chemotherapy, vol. 50, no. 7, pp. 2500–5 [Online]. Available at www.ncbi.nlm.nih.gov/ pmc/ articles/ PMC1489768/ (Accessed 23 November 2017).
NICE (2017) ‘Ceftraroline fosamil’ [Online[. Available at https://bnf.nice.org.uk/ drug/ ceftaroline-fosamil.html (Accessed 27 November 2017).
Pfizer (2017) Antimicrobial Testing Leadership and Surveillance (ATLAS) [Online]. Available at https://atlas-surveillance.com/ (Accessed 28 November 2017).
Public Health England (PHE) (2017) Antimicrobial Resistance (AMR) [Online]. Available at www.gov.uk/ government/ collections/ antimicrobial-resistance-amr-information-and-resources (Accessed 20 November 2017).
Woodford, N. and Ellington, M. J. (2007) ‘The emergence of antibiotic resistance by mutation’, Clinical Microbiology and Infection, vol. 13, pp. 5–18 [Online]. Available at http://onlinelibrary.wiley.com/ doi/ 10.1111/ j.1469-0691.2006.01492.x/ full (Accessed 20 November 2017).